Tirzepatide 15 mg produced 5.5 kg more weight loss than semaglutide 1 mg (p 25,000 participants in the SURPASS and SURMOUNT programs [1, 2, 3]: Gastrointestinal effects (most common, dose-dependent): Nausea: 12-18% (5 mg), 15-22% (10 mg), 18-28% (15 mg) vs
Verify your injection supplies (pen needles, alcohol swabs) are sufficient
For patients who have achieved massive weight loss, Dr
Not the First Time It wasn't the first time Pharm D had "sterility issues." In 2015, an FDA inspector cited numerous issues, including problems with the facility's aseptic processing area and failure to establish "procedures designed to prevent microbiological contamination." In 2016, the FDA sent a letter saying violations went back to 2014, and its "investigator observed serious deficiencies in your practices for producing sterile drug products, which put patients at risk." Not only was Pharm D Solutions allowed to continue doing business, but Texas renewed its license in 2017, the year before Reeh fell ill
Appetite suppression becomes stronger and more predictable between weeks 5 and 12 as the dose increases and satiety signals stabilize
Some people complain that theyre bloated, uncomfortable, and stuck